<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 243 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page242.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=243">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 243 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 243</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=243"><img src="../thumb/243.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>206 / 2020-04                                                               Ophthalmics - 15.6
   LOXOPTIC, (Gen-Eye) Actor Pharma [PWR]  keratit., tear., ocul.irrit .incl.blepharit., decr.corn.sens., dry eyes, con-  blepharit., eye pain, eyelidoed., blurr.vis., uveit./irit., macul. oed.,
   Betaxolol                    junctivit., sinusit., dysgeus., taste pervers., naus., asthen., fatig. Less   corn.oed./eros., palpebr. skin darken., bact. keratit., chest pain, ang.
   Indications: Low.IOP in chron.open angle glauc., elev.IOP.  freq: Bld.dyscras., SLE, S&S syst. allerg.reacts.incl.angioed./skin re-  pect., asthma aggravat./-attacks/cough & dyspn., URTI, colds & flu,
   (S3) OPHTH.SOL. 47/15.4/0526. 5 mg/ml.  acts./ shortn. of breath/anaphylax., hypersens., loc. reacts., psych./  skin rash, musc.-/joint-/back pain
   722010-001: 5 ml, R174,21    GI disords., dizzin., paraesthes., CNS effs., CVA, decr.libido, myasth.  Warnings and special precautions: Cont. high benzalkon.chlor.
   Dosage: Indiv. Usual dos: 1 drp. 2xdly. Syst. absorpt. reduc.when   grav.S&S incr., choroid. detachm.foll.filtrat.surg., corn.oed., iridocy-  conc.poss.absorb by cont.lens., potent. grad.incr.brown iris pigmen-
   using nasolacrim.occlus./ clos.eyelids x2 mins.  clit., ocul.hypotony, trans.myop., ptos. diplop., vis.disturbs.incl.refract.  tat. & poss. disparity betw.treat.& untreat. eye, eye colour chang.
   Contraindications: Card.shock/overt card.fail., sinus bradycard.,   chang., tinnit., card. disords.incl.card.arrest, CHF, dysrhythm., heart   mainly in mix.colour irides with onset within first 8 mnths.of ther.,
                    rd
                  nd
   sick sinus syndr., sino-atrial block, 2 /3  degr.AV block not contr.  block, vasc.disords.incl.cerebr.ischaem., claudicat., oed., Raynaud’s   eye lash /-lid changes, cyst.aphak./pseudophak.pts.with torn post.
   with pacemak., react.airway dis.incl.bronch.asthma /sev.bronch.  phenom., resp.fail., rhinit., epistax., bronchosp.esp.in bronchosp.dis.,   lens capsul./pts.with risk fact.for macul.oed., extend. use in pts.
   asthma hist./sev.COPD, damag. cornea, safety in pregn.not est.,   cough, dyspn., dry mouth, throat irrit., diarrh., dyspeps., naus., fulmin.  with extens.ocul.surf.dis., reg. ophthalmolog.exam.reqd., asthma
   safety & effic.in childr.not est.  hepat.necros., cont. dematit., Stev.Johns.syndr., tox. epiderm.necro-  aggravat./-attacks/ cough & dyspn.poss., ac.clos.angl.glauc. at-
   Side effects: Syst./skin reacts., allerg.reacts. incl. angioed., dis-  lys., alopec., psorias.exacerbat., SLE, urolithias., peyronie’s dis., sex.  tacks, limit.exper. in inflamm.ocul.condits./ inflamm. neovasc.angl.
   comf.& tear., decr.corn.sensitiv./ tear prod., corn. punct.stain./eros.,   dysfunct. Freq.unknown: Incr. in antinucl.antibod., non thrombocy-  clos./congenit.or pigment. glauc. /pseudophak.pts.with open angl.
   keratit., photophob., anisocor., ptos., diplop., blepharit., psych.disords.,   topen. purpura, thrombocytopen., trans.eosinophil., hypo-/hypergly-  glauc., ren./ hepat.impairm.
   CNS effs., headache, memory loss, syncope, CVA, cerebr. ischaem.,   caem., hallucinat., confus., itch./tear./ sore/red eye, blurr.vis., corn.  Drug interactions: IOP reduc.eff.is addit.to that of beta-adrenerg.
   incr.myasth.grav. S&S, dizzin., paraesthes., hypoglycaem., card.disor-  eros., pneumonit., pulm.-/ retroperiton.fibros., pleurisy, scleros. peri-  antagon./adrenerg.agonists (dipivefrin)/oral carbonic. anhydr.inhibit.
   ds.incl. mark.bradycard., CCF, chest pain, sev.periph.vasc. dis. & exac-  tonit., excess.sweat., prurit., arthralg., myopathy, musc,cramps, male   (acetazolamide) & partly with cholinerg.agonist (pilocarpine), precipi-
   erbat.thereof, Raynaud’s phenom., periph.gangrene, hypotens., cold/  impot., myalg., triglycerid.& cholester.conc.chang., rais.liv.enzym.  tat.occurs with eye drops cont. thiomersal, paradox.IOP elev.follow.
   cyanot.hands & feet, intermitt.claudicat. exacerbat., dyspn., asthma,   Warnings and special precautions: Resp./ card.reacts.incl.death   concom. admin. of two prostagland.analog.
   bronchosp.(death report), cough, GI disturbs., alopec., skelet.musc.  due to bronchosp./CF, not for use in mild to mod.COPD, sev.card.dis.  See also MDR page 107.
   weakn., myalg., sex.dysfunct., impot., decr.libido, poss.mask hyper-  hist./β-block. ther.adeq.contr.bef.init.ther., monit.CV dis. pts.for de-
   thyroid./ac. hypoglycaem.S&S.  terior.signs/adverse reacts., 1  degr. heart block, sev.periph.circulat.  TIMOPTOL, Mundipharma [PWR]
                                             st
   Warnings and special precautions: Secret.in human milk, lac-  disturbs./disords., poss. sev.adverse reacts./fatalit.due to sulphonam.   Timolol mal.
   tat., ren.decomposit., CF hist., 1  degr. heart block, discont.ther.when   react.incl.Stev. Johns.syndr./tox.epiderm. necrolys./ fulmin.hepat.ne-  Indications: Reduct.of elevat.IOP. Sol.also: concom.ther. in paed.
                st
   CF signs, CV dis., Prinzmetal’s ang., hypotens., bronchosp./ bronch.   cros./bld.dyscras., discont. if ser.reacts./hypersens./loc.adverse eff.   glauc.when inadeq.contr.
   asthma/ COPD or asthma hist., concom. adrenerg. psychotrop.meds./  esp. conjunctivit. & lid reacts.occur, pts.with hist. of sev.anaphylact.  (S3) SOL. K/15.4/339, 340.
   hypoglycaem.agents/ phenothiazin., soft cont.lens., dimin.respons.  reacts.to variety of allergens poss. more react.to repeat.challeng.&   770833-004: 2,5 mg/ml, 5 ml, R120,01
   with prolong. use., monit.for potent.addit.eff.with concom. oral ß-  poss. unrespons.to usual epinephrine dos., not recomm. in sev.ren.  770841-007: 5 mg/ml, 5 ml, R147,41
   blocks., diabet., thyrotoxicos., pts. subj. to spontan.hypoglycaem.,   impairm., no studies with hepat. impairm., concom.oral carbon.anhydr.  Dosage: Init: 1 drp. 0,25% sol.2xdly.in affect. eye(s). If respons.in-
   corn.dis./sicca syndr./ simil.tear film abnorm., pts.with hist.of atopy/   inhib.not recomm., concom.alpha-adrenocept.block.ther.to be giv. in   adeq.change dos.to 1 drp. 0,5% sol.2xdly.Other concom.IOP-reduc.
   sev.anaphylact.react.to a variety of allerg. poss. more react.to rep.  phaeochromocyt., withdr.grad.in coron. heart dis., corn.dis., may mask   ther.may be giv. Press. lower.respon.may req.sev.wks.to stabil. &
   challenge & may be unrespons. to usual adrenal.dos., syst.absorpt.,   hyperthyroid.signs, spontan. hypoglycaem./labile diab.as may mask   evaluat.should incl.IOP determinat.aft.approx.4 wks. If IOP satisfact.
   reg. ophthalmolog.exam.requir., monit.IOP reg.dur. treatm., tfd.from   ac.hypoglycaem.signs, surg./anaesthes., incr. urolithias.risk in pts.with   maint.consid.once dly.dos. ther.
   other sngl./sev.concom.agents, use with miot.in angle clos.glauc.,   ren.calculi hist., myasth. grav.poss.aggrav., not for use in ac.angl-clos.   Childr: Admin.concom.with other anti-glauc.meds. Init: 1 drp.
   poss. adverse eff. on corn.permeabil.& corn.epithel.with prolong. use.  glauc., soft cont.lens., poss.adverse eff.on corn. permeabil.& corn.  0,25% sol. 12 hrly. in affect.eye(s). May be incr.to 1 drp. 0,50%
   Drug interactions: Mydrias.with concom.ophth. epinephr., potent.  epithel.with prolong.use, reg. ophthalmolog.exam.reqd., extend.per.  sol.12 hrly.if necess.
   addit.eff.with oral Ca chann. blocks./ß-adrenerg.block.agents/anti-  use in extens. ocul.surf.dis., potent.incr.for corn.oed./ irrevers. corn.  Ref.to prod.lit.for instr.on transf.pts.from other ther.
   dysrhythm./ parasympathomimets/catecholamine.-deplet. agents.  decompensat.developm.in pts.with low endothel.cell counts &/intra-  (S3) XE GELLAN SOL. 29/15.4/0230, 0231.
                                                              819816-019: 2,5 mg/ml, 2,5 ml, R119,64
   LUMIGAN, Allergan [P/S]      ocul.surg.hist., choroid. detachm.poss. with Ocudor Co aft.filtrat. pro-  819824-003: 5 mg/ml, 2,5 ml, R147,21
                                ced., potent.addit.eff.on IOP/known ß-block. syst. effs.in pts.who are
   Bimatoprost                  receiv.ß-block.ther. system., use of 2 ß-adrenerg.blocks.not recomm.  Dosage: Init: 1 drp. 0,25% sol.1xdly. If respons. inadeq.admin.1
   Indications: Elev.IOP reduct.in chron.open-angle glauc./ ocul.hyper-  Interactions: Poss.mydrias.with concom. epinephrine, potent.syst.ß-  drp.0,50% sol.1xdly. Admin.other top. meds.no less than 10 mins.prior.
   tens.as monother.or as adjunct. ther. to ß-block.  blockade with concom. CYP2D6 inhib., poss.incr.hypoglycaem.eff.of   Ref.to prod.lit.for instr.on transf.pts.from other ther.
   (S4) EYE DROP SOL., 42/15.4/0835, 36/15.4/0157  antidiab. meds., excerbat.rebound hypertens.aft. clonidine withdr.,   Contraindications: Bronchosp.incl.bronch. asthma, COPD, un-
   716754-001: 0,1 mg/ml, 2,5 ml, R217,20  poss.addit.effs./hypotens.&/ mark. bradycard.with concom.oral Ca   controll.CF, sinus bradycard., 2nd/3rd degr. AV block, overt CF, car-
   703666-003: 0,3 mg/ml, 3 ml, R265,06  chann. block./ catecholamine deplet.meds.& ß-adrenerg. block.   diogen.shock
   Dosage: Admin.1 drp.in affect.eye(s) once dly in even. Max: once   agents/dysrhythm./digox./ parasympathomimets., guanethidine/  Side effects: Common: Headache, ocul. irritat.,conjunctivit.,
   dly.as more often may lessen eff. Admin.at least 5 mins.apart from   narcot./ MAOI’s.  blepharit., keratit., decr.corn.sensitiv., dry eyes. Uncommon: Diz-
   other top. ophthalm. meds.                                 zin., depress., vis.disturbs.incl.refract.changes, bradycard., syncope,
   Contraindications: Childr./adolesc., safety in pregn.& lactat. not est.  SAFLUTAN, Mundipharma &  dyspn., naus., dyspeps., asthen., fatig. Rare: Syst.lupus erythematos.,
   Side effects: Conjunctiv./ocul.hyperaem., eye. irrit. /prurit., punct.ker-  Tafluprost  insomn., nightmares, memory loss, paraesthes., incr.S&S of myasth.
   atit., asthenop., conjunct. disord./-oed., eyelid erythem.& prurit., eyelid   Indications: Elev.IOP reduct.in open-angle glauc./ ocul.hypertens.  grav., decr.libido, CVA, ptosis, diplop., choroid.detachm.follow.filtrat.
   marg. crust., eyelid oed., incr.eyelash growth, madaros., vis.disturbs.,   (S4) OPHTH.SOL, A45/15.4/0710. 15 µg/ml (4,5 µg/0,3 ml sngl.  surg., tinnit., hypotens., chest pain, palpitat., oed., arrhythm., CHF,
   hypertrichos./skin hyperpigmentat., hypersens., instill.site irrit., naus.,   dos.contain.)  heart block, card.arrest, cerebr.ischaem., claudicat., Raynaud’s, cold
   prurit., headache, allerg.conjunctivit., blepharit., blepharosp., cataract,   720401-001: 30 sngl.dos., R233,00  hand & feet, bronchosp., resp.fail., cough, diarrh., dry mouth, alopec.,
   corn.eros., cystoid macul.oed., eye discharge, eyelash darken., eyelid   Dosage: Admin.any other top.ophthal.product at least 5mins apart.   psoriasiform rash/psorias.exacerbat., Peyronie’s dis., hypersens. re-
   retract., eye pain, foreign body sensat., incr.iris/periocul.skin/blephar.   Wipe off any excess from eyelid skin ro reduc.risk of eyelid darken.   acts. Unest.causal relationship: Aphakic cystoid macul.oed., nas.
   pigmentat., iritis., ocul.burn./-dryn./-irrit./-discomf., photophob., retin.  Nasolacrim. occlus. aft.admin.recomm.to reduc.syst.absorpt.  congest., anorex., CNS effs.incl.psychic disturbs., hypertens., retro-
   haemorrh., tear., uveit., vis.acuity worsen., periorbit.erythem., dizzin.,   Recomm: 1 drp.in affect.eye once dly in the even.  periton.fibros., pseudo pemphigoid
   infects.esp. URTI, hypertens., asthen., periph.oed., hirsut., abnorm. hair   Side effects: Most comm: Ocul.hyperaem. Freq: Headache, eye   Warnings and special precautions: Reg. opthalm. exam.with pro-
   growth where sol.comes into rep.contact, bact.keratit., abnorm.LFT, peri-  prurit./-irrit./-pain, conjunctiv. hyperaem., eyelash changes, dry eye,   long.use, extens.surf.ocul. dis., asthma, bronchit., chron. resp.dis., 2   nd
   orbit./ lid chang. incl.deepen.of eyelid sulcus, asthma/-exacerbat., dyspn.  foreign body sensat. in eye, eyelash discolour., eyelid erythema, su-  & 3  degr.heart block, sinus bradycard. less than 50 bpm., periph.vasc.
                                                               rd
   Warnings and special precautions: Pts.with act. intraocul.inflam-  pefic. punct.keratit., photophob., incr.lacrimat., blurr. vis., reduc.vis.  dis., Raynauds, peri-op period, poss.choroid.detach.if admin.aft.filtrat.
   mat.as it may be exacerbat., avoid sol. runn.onto cheek/other skin   acuity, incr.iris pigmentat. Less freq: Blephar.-/conjunctiv.pigmentat.,   proc., known C/I’s to syst.beta-adrenerg.recept.block. agents, contr.CF
   areas, remove soft cont.lens.prior to admin.& wait &gt;15 mins. follow.  eyelid oed., asthenop., conjunctiv.oed, eye discharge, blepharit., anter.  prior to init.ther.& monit.sev.card. dis.hist.pts., poss.addit.effs.if oral
   admin.bef.reinsert, reg. ophthalmolog. exam., prolong.use in extens.  chamb.cells./-flare, conjunctiv. follicles., allerg.conjunctivit.& abnorm.  ß-adrenerg. recept. block.ther.admin., use in conjunct.with a miot.in
   ocul. surf. dis., concom.anti-glauc.agents other than topic. ß-block.   eye sensat., irit./ uveit., lid sulcus deepen., macul.-/cystoid macul. oed,   angle-clos.glauc., soft contact lense use, pts.with hist.of atopy/sev.
   not eval., ren./mod.to sev.hepat. impairm., advis.pts.of iris& eyelid   asthma exacerbat., dyspn., eyelid hypertrichos. Very rarely: Corn.  anaphylact.react.to a variety of allergens may be more react.to rep.
   pigmentat.& eyelash chang.esp.if only one eye is treat., compromis.   calcificat.in pts.with signif.damag.corneas.  challenge & poss.be unrespons.to usual adrenal. dos., poss.S/E of
   resp.funct., not stud.in heart block more sev.than 1  degr./uncon-  Warnings and special precautions: No exper. in neovasc./an-  oculo-cutan.syndr.type cannot be excl., myasth.grav., oral beta-adr-
                         st
   trol.CHF/inflamm. ocul. condits./neovasc.-/inflamm.-/angle-clos.-&   gle-clos./narr.-angle or congenit. glauc, aphak.pts, pseudophak.pts.  energ.block.poss exacerb.rebound hypertens.follow.clonidine withdr.,
   congenit.-or narr.angle glauc., aphakic pts./ pseudophakic pts.with   wih torn post. lens. caps, anter.chamber lenses, irit/uveit.known risk   digital.poss.necess.in pts.rec.long-term ther.if CCF likely., grad.withdr.
   torn poster.lens caps./mac. oed.risk fact., avoid touch.dispen.con-  fact., inform pt.of poss.eyelash growth/dark. eyelid skin & incr.iris pig-  & limit.phys. activ.dur. withdr.per., alpha-adrenerg.block.ther.in phaeo-
   tain.to eye/ any other surf., monit.pts.tak.concom. prostanglandin   mentat., hair growth where sol.comes in contact, sev.asthma, allow   chromocyt., outweigh benef.-risk in pregn.& lactat., pass.into breast
   analogs.for IOP chang.       poss. blurr.vis.to clear.bef.driv./operat.mach., ren. & hepat.insuffic.,   milk, use of 2 diff.topic. topic. ß-adrenerg.recept.block.not recomm.,
   Interactions: IOP-lower.eff.poss. reduc.in pts. with glauc./ocul.hy-  safety & effectiven.in childr. &lt;18 yrs./ pregn.& lactat.not est., effect.  transf. from other ther., sol.not recomm.for prems.& neonates, XE
   pertens.when used with other prostagland.analogs.  contracept. in women of child bear.age, embryotoxic./ teratogen. &   Sol: safety & effic.in childr.not est.
   OCUDOR CO, (Unicorn) Pharma Dynamics [Not permit. in   excret.in milk in anim.stud.  Interactions: Mydrias.with concom.adrenal., system. ß-block.po-
                                                              tent.with concom.CYP2D6 inhibits., poss.addit.effs.with oral Ca entry
                                See also MDR page 521.
   competit.in certain sports]                                block./ catecholamine deplet.meds./ß-adrenerg. block. agents, addit.
   Dorzolamide 20 mg, timolol 5 mg/ml.  SPERSATAN, Adcock Ingram [P/S] &  eff.in prolong.AV conduct.time with Ca antagon.& digital., rebound
   Indications: Elev.IOP in ocul.hypertens., open- angle/pseudoexfoliat.  Latanoprost  hypertens.follow. clonidine withraw.may be exacerbat.
   glauc./other second.open-angle glauc.when concom.ther.is appropr.  Indications: Elev.IOP reduc.in open angle glauc./ chron.clos.angl.
   (S3) EYE DROP SOL. 51/15.4/0162  glauc.& ocul.hypertens.   TRAVATAN, Novartis [P/S] &
   3000372-001: 5 ml, R178,85   (S4) OPHTH.SOL. 46/15.4/0918. 50 µg/ml.  Travoprost
   Dosage: 1 drp.2xdly.in affect.eye(s). When substit. for anoth.an-  723018-001: 2,5 ml, R166,48  Indications: Reduct.elev.IOP.in pts.with open-angle glauc./other
   tiglauc.agent discont.med.aft. complet. dly.dos.& start Ocudor Co   Dosage: If other topical ophthalmolog.meds.are being used admin.   ocul.hypertens.as monother./as adjunct.ther.
   the next day. Admin.at least 10 mins. apart if more than one oph-  at least 5 mins.apart. Remove contact lens.bef. admin.& wait at   (S4) SOL. 36/15.4/0333. 40 µg/ml
   thalm. med.used. Safety & effic.in paed.pts .bel. 2 yrs not est. Data   least 15 min.to reinsert.  702534-003: 2,5 ml, R209,69
   on safety & effic.insuff.in childr. 2-6 yrs.  Adults: 1 drp in affect.eye(s) once dly.pref.in even. Do not exceed   Dosage: Admin.at least 5 mins.apart from other top.ophthalm.meds.
   Contraindications: Bronch.asthma/hist.thereof, sev. chron.ob-  once dly dos. Cont.with next dos.as plann.if 1 dos.miss. IOP reduct.  1 drp.in conjunctiv.sac of affect.eye(s) once dly in even.
   struct.pulm.dis., sinus bradycard., 2nd/ 3rd degr.AV block, overt CF,   init.3-4  hrs aft. admin. with max.effect. obt.8-12 hrs.later.& maint.   Contraindications: Pregn., women attempt.to fall pregn., lactat.,
   cardiogen.shock, safety in pregn.& lactat.not est., not for admin.   for at least 24 hrs.  childr.und.18 yrs.
   while using soft cont.lens.  Contraindications: Pregn & lactat., childr., contact lens use  Side effects: Incr.pigmentat.of iris/periorbit.& periocul. tiss., incr.
   Side effects: Freq: Headache, blurr.vis., burn.& sting., corn.eros.,   Side effects: Incr.iris pigmentat., eye irrit., eye col.& eyelash chang.,   eyelash growth & discolourat., grad. change in eye col., skin irrit.,
   conjunctiv.inj., eyelid inflamm./-irrit., eye itch., superfic.punctuate   mild to mod.conjuctiv. hyperaem., trans.punctate epithel.eros.,   ocul./ conjunctiv. hyperaem., H.simplex, keratit.herpet., hypersens.,</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page242.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page238.html">238</a>&nbsp;&nbsp;&nbsp;<a href="page239.html">239</a>&nbsp;&nbsp;&nbsp;<a href="page240.html">240</a>&nbsp;&nbsp;&nbsp;<a href="page241.html">241</a>&nbsp;&nbsp;&nbsp;<a href="page242.html">242</a>&nbsp;&nbsp;&nbsp;<a href="page243.html">243</a>&nbsp;&nbsp;&nbsp;<a href="page244.html">244</a>&nbsp;&nbsp;&nbsp;<a href="page245.html">245</a>&nbsp;&nbsp;&nbsp;<a href="page246.html">246</a>&nbsp;&nbsp;&nbsp;<a href="page247.html">247</a>&nbsp;&nbsp;&nbsp;<a href="page248.html">248</a>
             </td>
             <td width="35%"><a href="page244.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page244.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
